Christopher Kelly, PA
Physician Assistant · Gilbert, WVNPI 1407137110
Payments from drug & device makers
Across 42 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$206
- Novo Nordisk$114
- AstraZeneca$76
- Abbott$67
- Novartis$58
- AbbVie$37
- plus $207 from 10 others
What the payments were for
- Food & beverage$74597%
- Education$203%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 11 | $206 |
| Novo Nordisk | 6 | $114 |
| AstraZeneca | 4 | $76 |
| Abbott | 3 | $67 |
| Novartis | 3 | $58 |
| AbbVie | 2 | $37 |
| Nevro Corp. | 2 | $36 |
| Pfizer | 2 | $33 |
| Merck | 2 | $26 |
| Bayer | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Amgen | 1 | $14 |
| GSK | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $12 |
How this compares
$765 in reported general payments places this provider in the 70th percentile of 833 physician assistant providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 134 | $216,161 |
| MounjaroTirzepatide | 149 | $215,628 |
| FarxigaDapagliflozin Propanediol | 141 | $173,538 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 87 | $118,987 |
| Repatha SureclickEvolocumab | 93 | $78,708 |
| EntrestoSacubitril/Valsartan | 61 | $73,773 |
| EliquisApixaban | 61 | $67,498 |
| Tresiba Flextouch U-200Insulin Degludec | 33 | $60,759 |
| XareltoRivaroxaban | 36 | $56,197 |
| TradjentaLinagliptin | 48 | $51,175 |
| LinzessLinaclotide | 37 | $45,300 |
| VascepaIcosapent Ethyl | 39 | $38,514 |
| SynjardyEmpagliflozin/Metformin Hcl | 39 | $38,349 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 11 | $37,889 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 21 | $29,747 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Xultophy 100-3.6 | $114 | $254,050145 claims |
| Lilly USA, LLCMounjaro, Trulicity | $17 | $241,444166 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $76 | $202,461180 claims |
| Boehringer IngelheimTradjenta, Synjardy, Synjardy Xr, Jardiance, Jentadueto | $206 | $187,540153 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta | $14 | $142,281118 claims |
| NovartisEntresto | $58 | $73,77361 claims |
| PfizerEliquis | $33 | $67,49861 claims |
| AbbVieLinzess | $37 | $45,30037 claims |
| BayerKerendia | $20 | $23,82121 claims |
| MerckJanuvia | $26 | $12,43715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Gilbert
- Amy ButtsWellsburg$258K
- Alexander EpperlySouth Charleston$21K
- Kelley WhoolerySouth Charleston$17K
- Jordan BrewerMorgantown$15K
- Tasha ElswickWinfield$14K
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Erik AndersonSouth Charleston$11K
- Catherine EnsingerParkersburg$11K
- Gregory PorterSouth Charleston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.